Skylight Health Submits Application for NASDAQ Capital Market Up-Listing

    NEXT STORY
    Nextech’s InfernoAR Signs Annual License Contract With National Association of Medicaid Directors (NAMD)
    PREV STORY
    Myovant Sciences and Pfizer Announce Positive One-Year Data from Phase 3 SPIRIT Extension Study of Once-Daily Relugolix Combination Therapy in Women with Endometriosis
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cerecor Announces Drawdown of $10 Million Tranche under its Debt Financing Agreement with Horizon Technology Finance

    author_avatar
    NASDAQ Market News

    Opioids Market Anticipated to Garner US$ 42,158.8 Mn by 2021 – Persistence Market Research

    Global Opioids Market Has Been Estimated to Account for US$ 34.8 Bn in 2015, ...

    author_avatar
    NASDAQ Market News

    Radius Health Receives FDA Fast Track Designation for Elacestrant (RAD1901)

    - Radius plans to initiate Phase 2 clinical study of elacestrant as a third-line ...

    author_avatar
    NASDAQ Market News